Skip to content

Clinical trials

Phase 3 Carcinoma, Squamous Cell trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Squamous Cell Phase: Phase 3 Country / region: United States Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20042
20061
20082
20111
20122
20141
20161
20173
20182
20191
20201
20211
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated7
Recruiting3
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Inovio Pharmaceuticals2
Introgen Therapeutics2
Pfizer2
AVEO Pharmaceuticals, Inc.1
Ariad Pharmaceuticals1
BioVex Limited1
Boehringer Ingelheim1
Celgene1
Galera Therapeutics, Inc.1
Genzyme, a Sanofi Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Squamous Cell24
Head and Neck Neoplasms7
Carcinoma, Non-Small-Cell Lung5
Squamous Cell Carcinoma of Head and Neck5
Carcinoma4
Carcinoma, Large Cell4
Adenocarcinoma2
Basal Cell Carcinoma2
Keratosis, Actinic2
Laryngeal Diseases2

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.